TherapeuticsMD Inc. (NASDAQ: TXMD)
$1.85
+0.0200 ( +1.09% ) 6.1K
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
Market Data
Open
$1.85
Previous close
$1.83
Volume
6.1K
Market cap
$21.52M
Day range
$1.84 - $1.87
52 week range
$1.43 - $4.35
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
10-q | Quarterly Reports | 65 | May 10, 2024 |
8-k | 8K-related | 16 | May 10, 2024 |
10-k/a | Quarterly Reports | 17 | Apr 29, 2024 |
8-k | 8K-related | 15 | Mar 29, 2024 |
10-k | Annual reports | 89 | Mar 29, 2024 |
4 | Insider transactions | 1 | Dec 07, 2023 |
4 | Insider transactions | 1 | Nov 17, 2023 |
8-k | 8K-related | 14 | Nov 14, 2023 |
10-q | Quarterly Reports | 70 | Nov 14, 2023 |
4 | Insider transactions | 1 | Aug 21, 2023 |